Tag Archives: novel and potent antimalarial drug candidate

Novartis published clinical trial results about novel and potent antimalarial drug candidate KAE609 (cipargamin)

KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over 20 years KAE609 was tested in adult patients with uncomplicated malaria and showed a median parasite clearance time of 12 … Read the full press release